|
|
 |
Estimating Regulatory Costs
Background
| The Issue
Before the government asks industry to take steps
to protect public health and the environment, it normally considers the
costs of compliance with any new regulatory requirements. Industry knows
that estimating costs is a critical step in the process, and generally
produces very conservative (highest possible) numbers. How much does
regulation actually cost? What does past experience tell us about the
accuracy of the cost estimates that regulatory agencies rely upon? How
can agencies avoid overestimating regulatory costs? |
Under nearly every law enacted by Congress to protect health, safety and the
environment, the cost of compliance is an important consideration in establishing
regulatory requirements. If the estimates of regulatory costs that the agencies
employ systematically overestimate those costs, the regulators may promulgate
less stringent health, safety and environmental requirements out of an unfounded
fear that protective standards will be too expensive and possibly result in
the loss of jobs. If broad assessments of the costs imposed by all health,
safety and environmental regulation are similarly biased upward, the debate
over the desirability of protective rules and legislation will become distorted
in favor of industry profits and at the expense of public health.
What People are Fighting About
Regulated industries constantly complain about the cost of complying with regulations
designed to address the risks that their activities pose to the public from
pollution, toxic substances, defective products, unsafe workplaces, and the
like. The individual companies that will be subject to particular regulations
nearly always raise the specter of debilitating costs when agencies consider
how stringent the regulations should be. Industry-sponsored think tanks periodically
publish eye-popping estimates of the overall costs of federal regulations with
the tacit (and sometimes explicit) suggestion that society is paying far too
high a price for health, safety and environmental protections. It’s not just
industry that argues that case; it has become a mainstay of anti-regulation
conservatives as well.
Supporters of existing regulatory programs respond that the broad cost estimates
produced by think tanks with ideological axes to grind have little or no empirical
basis and are, in fact, the predictable product of crude economic models designed
specifically to produce inflated estimates of regulatory costs. In the context
of individual rulemaking proceedings, cost projections invariably depend upon
the speculative predictions of the regulated companies themselves, hardly an
unbiased source of information on the matter, since they have a clear incentive
to inflate prospective regulatory costs. In addition, agency cost assessments
typically include costs that companies would have incurred whether or not the
regulations were promulgated, thus leading to further inflation of prospective
costs. All too often, global assessments of the overall costs that regulatory
programs have imposed on regulated industries are based not on retrospective
evaluations of the amounts that companies actually expended, but upon unvalidated
estimates made at the time that the regulations were being promulgated.
What’s At Stake?
- Whether artificially inflated cost estimates
deter the government from taking steps to protect people from harmful
practices.
- The ability of regulatory agencies to promulgate regulations that protect
health, safety and the environment at a reasonable cost. |
Moreover, when estimating prospectively the costs of individual rules, agencies
tend to adopt conservative assumptions that lead to overestimates, because they
know that regulatees are likely to challenge agency cost estimates in court.
The agencies also tend not to offer a range of cost estimates, but instead offer
only a single, inflated number. (For regulatory benefits, by contrast,
agencies typically offer a range of estimates.) The agencies also seldom discuss
the uncertainty surrounding their estimates of costs. One reason prospective
cost estimates are uncertain is that regulation frequently inspires technological
and operational innovations that lead to lower compliance costs.
Perhaps the most disturbing aspect of the public debate over the cost of federal
regulation is the very modest degree to which it is fueled by empirical data
on actual expenditures incurred in complying with past regulations. For example,
a recent estimate of the costs imposed by workplace health and safety regulations
prepared by the Mercatus Center at George Mason University simply added up the
cost projections that the relevant agency, the Occupational Safety and Health
Administration (OSHA), had made when it was promulgating 31 major regulations,
without undertaking any effort to determine whether the regulations had actually
cost as much as the agency had predicted, and multiplied that number by 5.55.
The “multiplier” was based upon a determination that companies spend $5.55 on
non-major OSHA regulations and OSHA fines for every dollar they spend complying
with major regulations, an estimate that was in turn based upon an unpublished
and otherwise unavailable 1974 report prepared by the National Association of
Manufacturers.
There are, in sum, strong reasons for concluding that prospective cost studies
are biased upward:.
- Agency analysts rely heavily upon the regulated companies for the empirical
data and assumptions underlying those estimates.
- Because they know that regulatees are likely to challenge cost estimates
in court, agencies tend to adopt conservative assumptions that lead to overestimates,
and they do not offer a range of cost estimates or an assessment of the uncertainty
surrounding their estimates of costs.
- Agency cost assessments typically include costs that companies would have
incurred whether or not the regulations were promulgated.
- Most cost assessments fail to anticipate the dynamic and innovative ways
in which regulatees react to regulations to minimize regulatory costs in the
real world.
The problem with inflated cost estimates is that they distort the regulatory
decision-making process. Protective regulatory options may fall by the wayside
because they appear to be too expensive, or “economically infeasible” to the
regulatory agencies. This can, in turn, lead the agencies to promulgate less
stringent protections than Congress intended or give them an excuse to decline
to promulgate any protections at all. For example, grossly inflated estimates
of the cost of installing airbags in automobiles caused the National Traffic
Safety Administration to delay that easily implemented requirement for more
than a decade. Similarly, inflated estimates of the overall impact of health,
safety and environmental regulations on the economy may distort national debates
over the desirability of governmental protections.
| Decisions on the Table
- How hard can the Environmental Protection Agency
push to force air and water polluters to control their discharges?
- How stringently can the Occupational Safety and Health Administration
regulate risky workplaces?
- What safety features can the Federal Motor Vehicle Safety Administration
require in 18-wheel trucks? |
CPR's Perspective
Both global and individual cost assessments fail to account for the realities
of company compliance with regulatory requirements. When retrospective cost
assessments are undertaken, they nearly always conclude that the regulated companies
expended far fewer resources in complying with health, safety and environmental
regulations than the agencies predicted at the time they promulgated the regulations.
Agencies should devote more resources to retrospective analyses aimed at correcting
bad estimates and preventing inflated cost estimates in the future. They should
also modify their day-to-day prospective cost estimates in the following ways:
- Agency-prepared cost estimates should include a “best case” analysis, in
addition to the “worst case” analysis that currently dominates cost estimates,
and they should include an “uncertainty analysis” that relates in an understandable
way the confidence the agency has in the estimates.
- Agencies should include a “technology improvement” scenario in cost assessments
in which companies are assumed to come up with innovative ways to comply with
proposed standards.
- In the absence of solid empirical data on actual compliance costs, agencies
should discount regulatory cost projections by a factor representing the probability
that technological improvements will result in reduced costs.
In the meantime, policymakers who rely on industry- and agency-prepared cost
assessments must take such assessments with several grains of salt. Courts
should be less reluctant to allow agencies to “force technology” by promulgating
stringent standards that may appear quite expensive when promulgated but usually
prove much less costly once the engineers for the companies put pen to paper.
Finally, the poor empirical basis for agency cost assessments and the reality
of upward bias in those predictions should put to rest suggestions that regulatory
agencies should be subject to a “regulatory budget” setting an overall cap on
the costs that they may impose on regulatees during any given year.
In Sum
When regulatory agencies promulgate standards and regulations to protect health,
safety and the environment, the companies that will ultimately have to comply
with those regulations frequently complain that they will cost too much. Surprisingly,
the source of the cost estimates that the agencies typically rely upon is the
regulated industry itself. Not surprisingly, these estimates tend to be seriously
inflated. Agencies should take steps to control cost estimates, and they should
not be deterred from promulgating stringent protections by industries crying
“wolf.”
|
 |
|